Publications by authors named "Mine Harada"

Claim this Profile
A
A comparative study of GVHD prophylaxis using low dose ATG versus PTCy for PBSCT based on two independent prospective cohorts.
Souichi Shiratori, Junichi Sugita, Jun Ishikawa, Takashi Kuroha, Yasuo Mori, Mine Harada

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma.
Yasuo Mori, Jun Takizawa, Yuna Katsuoka, Naoki Takezako, Koji Nagafuji, Mine Harada

Cancer Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor.
Junichi Sugita, Takashi Kuroha, Jun Ishikawa, Tetsuya Eto, Kentaro Fukushima, Mine Harada

Bone Marrow Transplant· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice.
Noriyuki Saito, Takuji Yamauchi, Noriaki Kawano, Rintaro Ono, Shuro Yoshida, Mine Harada

Int J Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation.
Junichi Sugita, Tomohiko Kamimura, Takayuki Ishikawa, Shuichi Ota, Tetsuya Eto, Mine Harada

Bone Marrow Transplant· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
Souichi Shiratori, Junichi Sugita, Shuichi Ota, Senji Kasahara, Jun Ishikawa, Mine Harada

Bone Marrow Transplant· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies.
Naoyuki Uchida, Kana Matsumoto, Toru Sakura, Michihiro Hidaka, Toshihiro Miyamoto, Mine Harada

Int J Hematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of red cell distribution width in hospitalized older patients with heart failure or infection.
Keitaro Nakashima, Eiichi Ohgami, Kazuhiko Kato, Souichi Yoshitomi, Toru Maruyama, Mine Harada

Geriatr Gerontol Int· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12).
Kazutaka Sunami, Morio Matsumoto, Shin-Ichi Fuchida, Eijiro Omoto, Hiroyuki Takamatsu, Mine Harada

Int J Clin Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide.
Junichi Sugita, Yusuke Kagaya, Toshihiro Miyamoto, Yasuhiko Shibasaki, Koji Nagafuji, Mine Harada

Bone Marrow Transplant· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.
Shin-Ichi Fuchida, Kazutaka Sunami, Morio Matsumoto, Hirokazu Okumura, Tohru Murayama, Mine Harada

Int J Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.
Shin-Ichi Fuchida, Kazutaka Sunami, Morio Matsumoto, Hirokazu Okumura, Tohru Murayama, Mine Harada

Int J Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Masahiro Ayano, Hiroshi Tsukamoto, Hiroki Mitoma, Yasutaka Kimoto, Mitsuteru Akahoshi, Mine Harada

Arthritis Res Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.
Toshihiro Miyamoto, Koji Nagafuji, Tomoaki Fujisaki, Naoyuki Uchida, Kosei Matsue, Mine Harada

Int J Hematol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04).
Tohru Murayama, Takahiro Fukuda, Hirokazu Okumura, Kazutaka Sunami, Aiko Sawazaki, Mine Harada

Int J Hematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: How do haematopoietic cell transplants cure leukaemia?
Mine Harada, Robert Peter Gale

Int J Hematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.
Junichi Sugita, Naomi Kawashima, Tomoaki Fujisaki, Kazuhiko Kakihana, Shuichi Ota, Mine Harada

Biol Blood Marrow Transplant· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TYK2 Promoter Variant and Diabetes Mellitus in the Japanese.
Seiho Nagafuchi, Yumi Kamada-Hibio, Kanako Hirakawa, Nobutaka Tsutsu, Masae Minami, Mine Harada

EBioMedicine· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of bone marrow-derived hematopoietic stem/progenitor cells to the generation of donor-marker⁺ cardiomyocytes in vivo.
Mitsuhiro Fukata, Fumihiko Ishikawa, Yuho Najima, Takuji Yamauchi, Yoriko Saito, Mine Harada

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of human autoimmune regulator (AIRE) gene translation by miR-220b.
Tomohito Matsuo, Yukiko Noguchi, Mieko Shindo, Yoshifumi Morita, Yoshie Oda, Mine Harada

Gene· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission.
Tetsuya Eto, Ken Takase, Toshihiro Miyamoto, Yuju Ohno, Tomohiko Kamimura, Mine Harada

Int J Hematol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus.
Makio Furukawa, Chikako Kiyohara, Takahiko Horiuchi, Hiroshi Tsukamoto, Hiroki Mitoma, Mine Harada

Mod Rheumatol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma.
Hiromitsu Daisaki, Ukihide Tateishi, Takashi Terauchi, Mitsuaki Tatsumi, Kazufumi Suzuki, Mine Harada

Ann Nucl Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study).
Koji Nagafuji, Toshihiro Miyamoto, Tetsuya Eto, Tomohiko Kamimura, Shuichi Taniguchi, Mine Harada

J Hematol Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
Yuan Kong, Yan-Rong Liu, Kai-Yan Liu, Xiao-Jun Huang, Fumihiko Ishikawa, Mine Harada

Zhongguo Shi Yan Xue Ye Xue Za Zhi· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis